Patents by Inventor Scott Hansen

Scott Hansen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11834669
    Abstract: Disclosed herein are cytomegalovirus vectors encoding fusion proteins comprising Mycobacterium tuberculosis (Mtb) antigens, nucleic acid molecules encoding the same, cytomegalovirus vectors comprising nucleic acid molecules, compositions comprising the same, and methods of eliciting an immune response against tuberculosis.
    Type: Grant
    Filed: July 1, 2021
    Date of Patent: December 5, 2023
    Assignees: International AIDS Vaccine Initiative, Inc., Oregon Health and Science University
    Inventors: Thomas G. Evans, Ravi Anantha, Aurelio M. Bonavia, Dominick J. Laddy, Louis Picker, Scott Hansen, Guangwu Xu
  • Publication number: 20230272036
    Abstract: The present invention provides CD8+ T cells comprising multi-specific T cell receptors and methods for making the same.
    Type: Application
    Filed: December 15, 2020
    Publication date: August 31, 2023
    Inventors: Klaus FRUEH, Louis PICKER, Jonah SACHA, Scott HANSEN, Benjamin BIMBER, Shaheed ABDULHAQQ
  • Publication number: 20230153782
    Abstract: Method and systems for tracking a solicitation of contributory payments from multiple parties in connection with a commercial transaction, such as a restaurant bill, by using an application that is trained by using a machine learning technique are provided. The method includes: receiving a notification that a transaction has been executed by a user; obtaining information that relates to the transaction; generating, based on the received information, a recommendation for soliciting contributions from potential participants with respect to the transaction; receiving information that relates to the potential participants; and receiving a confirmation of the recommendation. The generation of the recommendation may be implemented by applying a machine learning algorithm that is trained by using historical transaction data and/or data that relates to a merchant and/or a type of merchandise involved in the transaction.
    Type: Application
    Filed: November 10, 2022
    Publication date: May 18, 2023
    Applicant: JPMorgan Chase Bank, N.A.
    Inventors: Scott HANSEN, Christopher J. LEASOR, Adithya SAIRAMACHANDRAN, Ajithkumar R. NAIR
  • Patent number: 11410226
    Abstract: An advanced data platform may receive an asset pricing request containing information about an asset. An optimization engine may determine a predicted price for the asset at different locations and times and compute a price matrix accordingly. The engine may identify an optimized predicted price from the price matrix, taking into account the spatial and temporal factors and various optimization conditions. A view for presentation of the optimized predicted price for the asset on a client device is generated and communicated to the client device over a network. When the asset is a vehicle, the engine may compute a linear regression model that defines a set of input variables with associated regression coefficients, the set of input variables comprising input variables representing attributes describing the vehicle.
    Type: Grant
    Filed: December 4, 2020
    Date of Patent: August 9, 2022
    Assignee: J.D. Power
    Inventors: Oliver Thomas Strauss, Morgan Scott Hansen
  • Patent number: 11305015
    Abstract: CMV vectors that lack active UL128, UL130, UL146 and UL147 proteins that may also comprise one or more microRNA regulatory elements (MRE) that restrict expression of the CMV are provided. Immunization with CMV vectors having the described features allows selection of different CD8+ T cell responses—CD8+ T cells restricted by MHC-Ia, MHC-II, or by MHC-E.
    Type: Grant
    Filed: November 26, 2019
    Date of Patent: April 19, 2022
    Assignee: OREGON HEALTH & SCIENCE UNIVERSITY
    Inventors: Louis Picker, Scott Hansen, Klaus Frueh, Daniel Malouli, Jay Nelson, Jonah Sacha, Meaghan Hancock
  • Patent number: 11257101
    Abstract: A residual value forecasting system may utilize heterogeneous data, such as used market data, industry-specific data, and non-industry-specific data, from disparate data sources to produce residual value forecasts of an item based on a sophisticated residual value forecasting model particularly configured for agility. The system can dynamically and quickly adapt to change in data inputs and produce custom outputs. The system may determine a baseline value for an item using the used market data, a microeconomic factor using the industry-specific data, and a macroeconomic factor using the non-industry-specific data, as well as adjustments such as locality adjustments and modifications. Given the macroeconomic factor and the microeconomic factor relative to the locality-adjusted value of the item and in view of the competitive sets of similar and/or substitute items in the same industry, the system can generate an accurate forecast residual value of the item at a future time point.
    Type: Grant
    Filed: June 18, 2020
    Date of Patent: February 22, 2022
    Assignee: ALG, Inc.
    Inventors: Morgan Scott Hansen, Brian Izumi Abe, Oliver Thomas Sidney Strauss
  • Publication number: 20210403951
    Abstract: The present disclosure provides cytomegalovirus vectors encoding fusion proteins comprising Mycobacterium tuberculosis (Mtb) antigens, nucleic acid molecules encoding the same, cytomegalovirus vectors comprising nucleic acid molecules, compositions comprising the same, and methods of eliciting an immune response against tuberculosis.
    Type: Application
    Filed: July 1, 2021
    Publication date: December 30, 2021
    Inventors: Thomas G. Evans, Ravi Anantha, Aurelio M. Bonavia, Dominick J. Laddy, Louis Picker, Scott Hansen, Guangwu Xu
  • Publication number: 20210347219
    Abstract: An off-highway recreational vehicle having a longitudinal centerline includes a frame and a rear suspension. The rear suspension includes a left A-arm, wherein the left A-arm has a pivot axis, the pivot axis being on a right-hand side of the longitudinal centerline.
    Type: Application
    Filed: May 20, 2021
    Publication date: November 11, 2021
    Inventors: Devin Joseph Danielson, Adam Christian Krone, Nathan Len Wiater, Aaron Lee Swanson, Erick John Halvorson, Douglas Robert Grangroth, Kevin James Miller, Jared Richard Spindler, Leigh Raymond Collyer, Donald Scott Hansen, Joseph Patrick Wood
  • Patent number: 11091779
    Abstract: Methods of inducing a CD8+ T cell response to a heterologons antigen in which at least 10% of the CD8+ T cells are MHC-E restricted are disclosed. The method involves immunizing with a CMV vector that does not express UL128 and UL130 proteins. Also disclosed are recombinant CMV vectors comprising nucleic acids encoding a heterologous protein antigen, a UL40 protein, and a US28 protein but that do not express an active UL128 and UL130 protein. Also, disclosed are recombinant CMV vectors comprising nucleic acids encoding a heterologous protein antigen, but that do not express an active UL40 protein, UL128 protein, UL130 protein, and optionally a US28 protein. Also disclosed are recombinant CMV vectors comprising nucleic acids encoding a heterologous protein antigen, but that do not express an active US28 protein, UL128 protein, UL130 protein, and optionally a UL40 protein.
    Type: Grant
    Filed: January 9, 2020
    Date of Patent: August 17, 2021
    Assignee: OREGON HEALTH & SCIENCE UNIVERSITY
    Inventors: Klaus Frueh, Louis Picker, Scott Hansen, Jonah Sacha, Daniel Malouli
  • Patent number: 11091775
    Abstract: The present disclosure provides cytomegalovirus vectors encoding fusion proteins comprising Mycobacterium tuberculosis (Mtb) antigens, nucleic acid molecules encoding the same, cytomegalovirus vectors comprising nucleic acid molecules, compositions comprising the same, and methods of eliciting an immune response against tuberculosis.
    Type: Grant
    Filed: June 21, 2017
    Date of Patent: August 17, 2021
    Assignees: Oregon Health and Science University, International AIDS Vaccine Initative, Inc.
    Inventors: Thomas G. Evans, Ravi P. Anantha, Aurelio M. Bonavia, Dominick J. Laddy, Louis Picker, Scott Hansen, Guangwu Xu
  • Patent number: 11014419
    Abstract: An off-highway recreational vehicle having a longitudinal centerline includes a frame and a rear suspension. The rear suspension includes a left A-arm, wherein the left A-arm has a pivot axis, the pivot axis being on a right-hand side of the longitudinal centerline.
    Type: Grant
    Filed: March 21, 2018
    Date of Patent: May 25, 2021
    Assignee: ARCTIC CAT INC.
    Inventors: Devin Joseph Danielson, Adam Christian Krone, Nathan Len Wiater, Aaron Lee Swanson, Erick John Halvorson, Douglas Robert Grangroth, Kevin James Miller, Jared Richard Spindler, Leigh Raymond Collyer, Donald Scott Hansen, Joseph Patrick Wood
  • Publication number: 20210110468
    Abstract: An advanced data platform may receive an asset pricing request containing information about an asset. An optimization engine may determine a predicted price for the asset at different locations and times and compute a price matrix accordingly. The engine may identify an optimized predicted price from the price matrix, taking into account the spatial and temporal factors and various optimization conditions. A view for presentation of the optimized predicted price for the asset on a client device is generated and communicated to the client device over a network. When the asset is a vehicle, the engine may compute a linear regression model that defines a set of input variables with associated regression coefficients, the set of input variables comprising input variables representing attributes describing the vehicle.
    Type: Application
    Filed: December 4, 2020
    Publication date: April 15, 2021
    Inventors: Oliver Thomas Strauss, Morgan Scott Hansen
  • Patent number: 10878491
    Abstract: An advanced data platform may receive an asset pricing request containing information about an asset. An optimization engine may determine a predicted price for the asset at different locations and times and compute a price matrix accordingly. The engine may identify an optimized predicted price from the price matrix, taking into account the spatial and temporal factors and various optimization conditions. A view for presentation of the optimized predicted price for the asset on a client device is generated and communicated to the client device over a network. When the asset is a vehicle, the engine may compute a linear regression model that defines a set of input variables with associated regression coefficients, the set of input variables comprising input variables representing attributes describing the vehicle.
    Type: Grant
    Filed: September 13, 2019
    Date of Patent: December 29, 2020
    Assignee: ALG, INC.
    Inventors: Oliver Thomas Strauss, Morgan Scott Hansen
  • Publication number: 20200392534
    Abstract: Methods of inducing a CD8+ T cell response to a heterologons antigen in which at least 10% of the CD8+ T cells are MHC-E restricted are disclosed. The method involves immunizing with a CMV vector that does not express UL128 and UL130 proteins. Also disclosed are recombinant CMV vectors comprising nucleic acids encoding a heterologous protein antigen, a UL40 protein, and a US28 protein but that do not express an active UL128 and UL130 protein. Also, disclosed are recombinant CMV vectors comprising nucleic acids encoding a heterologous protein antigen, but that do not express an active UL40 protein, UL128 protein, UL130 protein, and optionally a US28 protein. Also disclosed are recombinant CMV vectors comprising nucleic acids encoding a heterologous protein antigen, but that do not express an active US28 protein, UL128 protein, UL130 protein, and optionally a UL40 protein.
    Type: Application
    Filed: January 9, 2020
    Publication date: December 17, 2020
    Inventors: Klaus FRUEH, Louis PICKER, Scott HANSEN, Jonah SACHA, Daniel MALOULI
  • Publication number: 20200368333
    Abstract: Disclosed herein are recombinant CMV vectors comprising heterologous antigens and microRNA recognition elements to silence expression of CMV genes in the presence of microRNA derived from myeloid cells, an active UL128 protein and an active UL130 protein. Also disclosed are recombinant CMV vectors comprising heterologous antigens and microRNA recognition elements to silence expression of CMV genes in the presence of microRNA derived from myeloid cells, an inactive UL128 protein and an inactive UL130 protein. Also disclosed are methods of generating an unconventional immune response using these vectors. Such an immune response is characterized by generation of a CD8+ T cell response that is predominantly restricted by MHC-II.
    Type: Application
    Filed: May 8, 2020
    Publication date: November 26, 2020
    Inventors: Jay NELSON, Scott HANSEN, Meaghan H. HANCOCK, Louis PICKER, Klaus FRUEH
  • Publication number: 20200320556
    Abstract: A residual value forecasting system may utilize heterogeneous data, such as used market data, industry-specific data, and non-industry-specific data, from disparate data sources to produce residual value forecasts of an item based on a sophisticated residual value forecasting model particularly configured for agility. The system can dynamically and quickly adapt to change in data inputs and produce custom outputs. The system may determine a baseline value for an item using the used market data, a microeconomic factor using the industry-specific data, and a macroeconomic factor using the non-industry-specific data, as well as adjustments such as locality adjustments and modifications. Given the macroeconomic factor and the microeconomic factor relative to the locality-adjusted value of the item and in view of the competitive sets of similar and/or substitute items in the same industry, the system can generate an accurate forecast residual value of the item at a future time point.
    Type: Application
    Filed: June 18, 2020
    Publication date: October 8, 2020
    Inventors: Morgan Scott Hansen, Brian Izumi Abe, Oliver Thomas Sidney Strauss
  • Publication number: 20200237915
    Abstract: Disclosed are CMV vectors that lack active UL128, UL130, UL146 and UL147 proteins that may also comprise one or more microRNA regulatory elements (MRE) that restrict expression of the CMV. Immunization with the disclosed CMV vectors allow selection of different CD8+ T cell responses—CD8+ T cells restricted by MHC-Ia, MHC-II, or by MHC-E.
    Type: Application
    Filed: November 26, 2019
    Publication date: July 30, 2020
    Inventors: Louis PICKER, Scott Hansen, Klaus Frueh, Daniel Malouli, Jay Nelson, Jonah Sacha, Meaghan Hancock
  • Patent number: 10726430
    Abstract: A residual value forecasting system may utilize heterogeneous data, such as used market data, industry-specific data, and non-industry-specific data, from disparate data sources to produce residual value forecasts of an item based on a sophisticated residual value forecasting model particularly configured for agility. The system can dynamically and quickly adapt to change in data inputs and produce custom outputs. The system may determine a baseline value for an item using the used market data, a microeconomic factor using the industry-specific data, and a macroeconomic factor using the non-industry-specific data, as well as adjustments such as locality adjustments and modifications. Given the macroeconomic factor and the microeconomic factor relative to the locality-adjusted value of the item and in view of the competitive sets of similar and/or substitute items in the same industry, the system can generate an accurate forecast residual value of the item at a future time point.
    Type: Grant
    Filed: September 6, 2019
    Date of Patent: July 28, 2020
    Assignee: ALG, Inc.
    Inventors: Morgan Scott Hansen, Brian Izumi Abe, Oliver Thomas Sidney Strauss
  • Patent number: 10688164
    Abstract: Disclosed herein are recombinant CMV vectors comprising heterologous antigens and microRNA recognition elements to silence expression of CMV genes in the presence of microRNA derived from myeloid cells, an active UL128 protein and an active UL130 protein. Also disclosed are recombinant CMV vectors comprising heterologous antigens and microRNA recognition elements to silence expression of CMV genes in the presence of microRNA derived from myeloid cells, an inactive UL128 protein and an inactive UL130 protein. Also disclosed are methods of generating an unconventional immune response using these vectors. Such an immune response is characterized by generation of a CD8+ T cell response that is predominantly restricted by MHC-II.
    Type: Grant
    Filed: November 20, 2016
    Date of Patent: June 23, 2020
    Assignee: OREGON HEALTH & SCIENCE UNIVERSITY
    Inventors: Jay Nelson, Scott Hansen, Meaghan H. Hancock, Louis Picker, Klaus Frueh
  • Patent number: 10685363
    Abstract: Systems, methods and computer program products for forecasting future values of an item, where an initial value for the item is determined, and then a baseline forecast for a future reference period is computed based on factors that include microeconomic data which is specific to an industry of the item and macroeconomic data which is non-specific to the industry of the item. The forecast may also be adjusted based on data for a set of competitive items. The forecast for the item is stored and is then made available to clients that can access the forecast to determine the expected future value of the item at some point in the future.
    Type: Grant
    Filed: July 25, 2019
    Date of Patent: June 16, 2020
    Assignee: ALG, Inc.
    Inventors: Oliver Thomas Strauss, Morgan Scott Hansen